Dragon Pharma FOXO4-DRI 10 mg
Dragon Pharma's FOXO4-DRI 10 mg is a groundbreaking experimental synthetic peptide that represents one of the most exciting developments in the field of senolytics and anti-aging research. This innovative peptide is specifically designed to function as a potent senolytic agent, selectively targeting and eliminating senescent cells—often referred to as "zombie cells"—from the body without causing harm to healthy, functioning cells.
Senescent cells are cells that have stopped dividing but refuse to die, accumulating in tissues throughout the body as we age. These dysfunctional cells secrete harmful inflammatory signals known as the senescence-associated secretory phenotype (SASP), which damages surrounding tissues, contributes to chronic inflammation, and accelerates the aging process. The accumulation of senescent cells has been linked to a wide range of age-related conditions, including reduced muscle mass, decreased joint function, impaired recovery, and overall decline in physical performance.
FOXO4-DRI works through a highly sophisticated and targeted mechanism. It specifically disrupts the binding interaction between the FOXO4 protein and the tumor suppressor protein p53. In senescent cells, FOXO4 sequesters p53, preventing it from triggering programmed cell death (apoptosis). By competitively binding to p53, FOXO4-DRI liberates p53, allowing it to initiate the apoptosis cascade specifically in senescent cells. Healthy cells, which have different p53 dynamics, are unaffected by this process, making FOXO4-DRI remarkably selective.
For bodybuilders and athletes, the implications of this mechanism are profound. As we age and accumulate senescent cells, muscle tissue repair and regeneration become less efficient. Recovery from intense training slows down, injury risk increases, and the ability to build and maintain muscle mass declines. By systematically removing senescent cells, FOXO4-DRI helps clear the way for healthier cells to function optimally, potentially restoring tissue function and improving overall physiological performance.
Research on FOXO4-DRI has demonstrated remarkable results. In preclinical studies, a single injection of FOXO4-DRI restored fur density, reduced frailty, improved renal function, and even extended the lifespan of aged mice. For athletes and fitness enthusiasts, this translates to potential benefits such as improved recovery from training, enhanced tissue repair and regeneration, reduced inflammation, increased energy levels, and better overall physical function. The peptide's ability to rejuvenate aged tissues makes it particularly relevant for experienced athletes looking to maintain peak performance as they age.
Furthermore, the systemic reduction of senescent cells may have cascading positive effects on various bodily systems. By reducing the chronic low-grade inflammation characteristic of aging, FOXO4-DRI may support cardiovascular health, metabolic function, and even cognitive performance. For those using anabolic steroids, which can accelerate cellular aging and stress in certain tissues, FOXO4-DRI offers a novel approach to mitigating some of these long-term concerns.
It is important to note that FOXO4-DRI is an experimental peptide intended for research and personal development use. The science behind senolytics is rapidly evolving, and FOXO4-DRI stands at the forefront of this exciting field. Users should approach it with the same respect and careful consideration they would give to any powerful biological agent, recognizing its potential to produce profound effects on cellular health and overall well-being.
Key Benefits:
- Senescent Cell Clearance: Selectively targets and eliminates aged "zombie" cells that accumulate in tissues, clearing the way for healthier cellular function.
- Reduced Inflammation: Decreases the chronic inflammatory signals (SASP) produced by senescent cells, potentially improving recovery and reducing joint pain.
- Enhanced Tissue Regeneration: By removing dysfunctional cells, creates an environment conducive to improved tissue repair, muscle growth, and recovery from injury.
- Anti-Aging Effects: Addresses cellular aging at its source, potentially improving physical function, energy levels, and overall vitality.
- Targeted p53 Pathway Activation: Specifically disrupts the FOXO4-p53 interaction, triggering apoptosis exclusively in senescent cells while leaving healthy cells completely unaffected.
Each package contains one 2 mL glass vial with 10 mg of lyophilized FOXO4-DRI powder, manufactured under strict quality control standards in Dragon Pharma's certified European facilities. The product requires reconstitution with bacteriostatic water prior to use.
Product Specifications
| Product Name |
FOXO4-DRI 10 mg |
| Manufacturer |
Dragon Pharma |
| Substance |
FOXO4-DRI (Senolytic Peptide) |
| Packaging |
2 mL Glass Vial (Lyophilized Powder) |
| Lab Test Result |
HPLC Verified (≥98% Purity) |
| Half-Life |
Approximately 4-6 hours |
| Recommended Cycle |
Single injection or 2-4 week protocol |
| Form |
Lyophilized Powder |
| Aromatization |
No |
| Dosage (Men) |
1-2 mg single dose or 100-250 mcg daily |
Usage Guidelines
FOXO4-DRI is typically administered via subcutaneous injection after reconstitution with bacteriostatic water. Based on emerging research and user experience, the following protocols have been explored for senolytic effects.
- Single Injection Protocol: A single dose of 1-2 mg administered subcutaneously. This protocol is based on the groundbreaking research showing significant effects from a single administration. Ideal for first-time users looking to assess response.
- Short-Cycle Protocol: 100-250 mcg administered daily for 2 weeks. This protocol is designed for more sustained senolytic effects and is commonly used by advanced users.
- Maintenance Protocol: 100-150 mcg administered once weekly for 4 weeks. This approach is for those looking to maintain the benefits of senescent cell clearance over time.
Recommended Stacking Strategies:
FOXO4-DRI can be strategically combined with other Dragon Pharma products for comprehensive health optimization. For enhanced cellular health and mitochondrial support, stacking with SS-31 50 mg provides synergistic benefits for cellular energy and function. For those seeking overall tissue regeneration and recovery, TB-500 5 mg offers complementary healing properties. For comprehensive immune support and systemic health, combining with Thymosin Alpha-1 10 mg can enhance overall well-being. For users focused on cognitive health alongside cellular rejuvenation, Semax 5 mg provides neuroprotective benefits that pair well with FOXO4-DRI's senolytic effects.
Health & Ancillary Support:
While FOXO4-DRI does not affect hormonal pathways directly, maintaining overall health is essential for optimal results. For athletes using anabolic steroids, comprehensive cardiovascular support is critical—consider incorporating Atorvastatin 40 mg for lipid management. Additionally, proper hydration, adequate sleep, and a nutrient-dense diet are crucial to maximizing the benefits of this peptide. A healthy lifestyle with regular exercise and stress management will complement the senolytic effects of FOXO4-DRI.
Storage Instructions
Proper storage is essential to maintain the integrity and potency of FOXO4-DRI.
- Lyophilized Powder: Store in a cool, dry place away from direct light at room temperature (up to 25°C / 77°F).
- Post-Reconstitution: Once mixed with bacteriostatic water, the solution must be refrigerated at 2-8°C (36-46°F).
- Stability: Use the reconstituted solution within 28-30 days to ensure optimal peptide efficacy.
- Important: Do not freeze the reconstituted solution, as this can degrade the peptide structure.
Frequently Asked Questions
What is FOXO4-DRI and how does it work?
FOXO4-DRI is a senolytic peptide designed to selectively eliminate senescent ("zombie") cells. It works by disrupting the binding between FOXO4 and p53 proteins, liberating p53 to trigger programmed cell death (apoptosis) specifically in aged cells. Healthy cells are unaffected, making it a highly targeted approach to cellular rejuvenation.
How do I reconstitute FOXO4-DRI 10 mg?
To reconstitute FOXO4-DRI, add 2 mL of bacteriostatic water to the vial. Gently swirl until the powder is fully dissolved. Avoid shaking vigorously. This yields a concentration of 5 mg/mL for accurate dosing. Always use sterile techniques and equipment.
What are the recommended dosages for FOXO4-DRI?
Based on research and user experience, common protocols include a single dose of 1-2 mg, daily dosing of 100-250 mcg for 2 weeks, or weekly maintenance doses of 100-150 mcg for 4 weeks. Beginners should start with the single injection protocol to assess response.
Can FOXO4-DRI be stacked with other peptides?
Yes, FOXO4-DRI stacks effectively with other peptides for enhanced results. Common combinations include SS-31 for mitochondrial support, TB-500 for tissue regeneration, Thymosin Alpha-1 for immune health, and Semax for cognitive support. Always research compatibility and use appropriate cycling protocols.
What are the benefits of FOXO4-DRI for bodybuilders and athletes?
FOXO4-DRI offers several benefits for athletes: eliminates senescent cells that impair tissue regeneration, reduces chronic inflammation that hinders recovery, creates an optimal environment for muscle repair and growth, addresses age-related declines in physical performance, and may improve overall vitality and energy levels. By clearing aging cells, it helps athletes maintain peak performance and recover faster from intense training.
